LOW CYCLO: Study Evaluating the Benefit of Two Doses of Ciclosporine in de Novo Cardiac Transplant

NCT00159159 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

106

Enrollment

OTHER

Sponsor class

Conditions

Cardiac Transplantion

Interventions

DRUG: Ciclosporine 130 µg/l < T0 ciclosporinemia < 200 µg/l
DRUG: Ciclosporine 200 µg/l < T0 ciclosporinemia < 300 µg/l

Sponsor

Hospices Civils de Lyon